Radiology, Vol 193, 513-517, Copyright © 1994 by Radiological Society of North America

ARTICLES

Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients

TP Chambers, RL Baron and RM Lush
Department of Radiology, University of Pittsburgh Medical Center, PA 15213-2582.

PURPOSE: To evaluate the effects of alterations in the volume of contrast material on liver enhancement. MATERIALS AND METHODS: Thirty patients underwent repeat computed tomographic (CT) examinations within 6 months, the first with either 100, 150, or 180 mL of nonionic contrast material (2 mL/sec). In the second, only volume was altered. Liver attenuation was measured before and after contrast material administration, and enhancement was calculated for each image. Comparisons were made only within the same patients. RESULTS: Mean liver enhancement was greater with 150 mL compared with 100 mL beyond 55 seconds after injection. Mean peak enhancement was greater by 21 HU with 150 mL; mean time to peak enhancement was longer by 14 seconds. Mean liver enhancement was greater with 180 mL compared with 150 mL at all intervals beyond 80 seconds. Mean peak enhancement was greater by 22 HU; mean time to peak liver enhancement was longer by 24 seconds. CONCLUSION: Alterations in contrast material volume have substantial impact on liver enhancement and potentially tumor conspicuity. The optimal window of time for liver imaging after contrast material injection varies with the volume administered.

This article has been cited by other articles:

				K. T. Bae, B. A. Seeck, C. F. Hildebolt, C. Tao, F. Zhu, M. Kanematsu, and P. K. Woodard Contrast Enhancement in Cardiovascular MDCT: Effect of Body Weight, Height, Body Surface Area, Body Mass Index, and Obesity Am. J. Roentgenol., March 1, 2008; 190(3): 777 - 784. [Abstract] [Full Text] [PDF]

				A. Furuta, K. Ito, T. Fujita, S. Koike, A. Shimizu, and N. Matsunaga Hepatic Enhancement in Multiphasic Contrast-Enhanced MDCT: Comparison of High- and Low-Iodine-Concentration Contrast Medium in Same Patients with Chronic Liver Disease Am. J. Roentgenol., July 1, 2004; 183(1): 157 - 162. [Abstract] [Full Text] [PDF]

				M. Imbriaco, A. J. Megibow, L. Camera, L. Pace, P. P. Mainenti, M. Romano, G. Selva, and M. Salvatore Dual-Phase Versus Single-Phase Helical CT to Detect and Assess Resectability of Pancreatic Carcinoma Am. J. Roentgenol., June 1, 2002; 178(6): 1473 - 1479. [Abstract] [Full Text] [PDF]

				T. Kim, M. P. Federle, R. L. Baron, M. S. Peterson, and Y. Kawamori Discrimination of Small Hepatic Hemangiomas from Hypervascular Malignant Tumors Smaller than 3 cm with Three-Phase Helical CT Radiology, June 1, 2001; 219(3): 699 - 706. [Abstract] [Full Text] [PDF]

				B. R. Herts, C. M. O'Malley, S. L. Wirth, M. L. Lieber, and B. Pohlman Power Injection of Contrast Media Using Central Venous Catheters: Feasibility, Safety, and Efficacy Am. J. Roentgenol., February 1, 2001; 176(2): 447 - 453. [Abstract] [Full Text] [PDF]

				Y. Yamashita, Y. Komohara, M. Takahashi, M. Uchida, N. Hayabuchi, T. Shimizu, and I. Narabayashi Abdominal Helical CT: Evaluation of Optimal Doses of Intravenous Contrast Material-A Prospective Randomized Study Radiology, September 1, 2000; 216(3): 718 - 723. [Abstract] [Full Text]

				B. S. Kuszyk, D. A. Bluemke, M. A. Choti, K. M. Horton, C. A. Magee, and E. K. Fishman Contrast-Enhanced CT of Small Hypovascular Hepatic Tumors: Effect of Lesion Enhancement on Conspicuity in Rabbits Am. J. Roentgenol., February 1, 2000; 174(2): 471 - 0. [Abstract] [Full Text] [PDF]

				T. Kim, T. Murakami, S. Takahashi, A. Okada, M. Hori, Y. Narumi, and H. Nakamura Pancreatic CT Imaging: Effects of Different Injection Rates and Doses of Contrast Material Radiology, July 1, 1999; 212(1): 219 - 225. [Abstract] [Full Text]